NO20023476L - Höyrenhets lipopeptider, lipopeptid miceller og fremgangsmåte for fremstilling av disse og farmasöytiske sammensetninger sominneholder dem - Google Patents

Höyrenhets lipopeptider, lipopeptid miceller og fremgangsmåte for fremstilling av disse og farmasöytiske sammensetninger sominneholder dem

Info

Publication number: NO20023476L
Authority: NO; Norway
Prior art keywords: discloses; daptomycin; methods; micelles; lipopeptide
Prior art date: 2000-01-20

Application number

NO20023476A

Other languages

English (en)

Norwegian (no)

Other versions

NO20023476D0 (no

Inventor

Thomas J Kelleher

Jan-Ji Lai

Joseph P Decourcey

Paul D Lynch

Maurizio Zenoni

Auro R Tagliani

Original Assignee

Cubist Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-20

Filing date

2002-07-19

Publication date

2002-09-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26873002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20023476(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-07-19 Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc

2002-07-19 Publication of NO20023476D0 publication Critical patent/NO20023476D0/no

2002-09-20 Publication of NO20023476L publication Critical patent/NO20023476L/no

Links

108010028921 Lipopeptides Proteins 0.000 title abstract 6
238000000034 method Methods 0.000 title abstract 6
239000000693 micelle Substances 0.000 title abstract 5
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
108010013198 Daptomycin Proteins 0.000 abstract 6
DOAKLVKFURWEDJ-QCMAZARJSA-N daptomycin Chemical compound C([C@H]1C(=O)O[C@H](C)[C@@H](C(NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C(=O)N1)[C@H](C)CC(O)=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CCCCCCCCC)C(=O)C1=CC=CC=C1N DOAKLVKFURWEDJ-QCMAZARJSA-N 0.000 abstract 6
229960005484 daptomycin Drugs 0.000 abstract 6
238000005571 anion exchange chromatography Methods 0.000 abstract 3
241000958215 Streptomyces filamentosus Species 0.000 abstract 1
238000004458 analytical method Methods 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
229940088710 antibiotic agent Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000000855 fermentation Methods 0.000 abstract 1
230000004151 fermentation Effects 0.000 abstract 1
238000004128 high performance liquid chromatography Methods 0.000 abstract 1
238000004191 hydrophobic interaction chromatography Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Analytical Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Compounds Of Unknown Constitution (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO20023476A 2000-01-20 2002-07-19 Höyrenhets lipopeptider, lipopeptid miceller og fremgangsmåte for fremstilling av disse og farmasöytiske sammensetninger sominneholder dem NO20023476L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17717000P	2000-01-20	2000-01-20
US09/735,191 US6696412B1 (en)	2000-01-20	2000-11-28	High purity lipopeptides, Lipopeptide micelles and processes for preparing same
PCT/US2001/001748 WO2001053330A2 (en)	2000-01-20	2001-01-18	High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them

Publications (2)

Publication Number	Publication Date
NO20023476D0 NO20023476D0 (no)	2002-07-19
NO20023476L true NO20023476L (no)	2002-09-20

Family

ID=26873002

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023476A NO20023476L (no)	2000-01-20	2002-07-19	Höyrenhets lipopeptider, lipopeptid miceller og fremgangsmåte for fremstilling av disse og farmasöytiske sammensetninger sominneholder dem

Country Status (25)

Country	Link
US (7)	US6696412B1 (de)
EP (6)	EP2159229A1 (de)
JP (2)	JP5303087B2 (de)
KR (4)	KR101174140B1 (de)
CN (5)	CN107082798B (de)
AT (2)	ATE449785T1 (de)
AU (1)	AU784937B2 (de)
BR (1)	BRPI0107731B8 (de)
CA (2)	CA2743326C (de)
CY (2)	CY1109846T1 (de)
CZ (2)	CZ307877B6 (de)
DE (2)	DE60140631D1 (de)
DK (2)	DK1586580T3 (de)
ES (4)	ES2799702T3 (de)
HK (6)	HK1054240A1 (de)
HU (1)	HUP0203969A2 (de)
IL (3)	IL150733A0 (de)
IS (1)	IS6470A (de)
MX (1)	MXPA02007132A (de)
NO (1)	NO20023476L (de)
NZ (1)	NZ520324A (de)
PL (3)	PL226956B1 (de)
PT (2)	PT1586580E (de)
RU (1)	RU2311460C9 (de)
WO (1)	WO2001053330A2 (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6696412B1 (en) *	2000-01-20	2004-02-24	Cubist Pharmaceuticals, Inc.	High purity lipopeptides, Lipopeptide micelles and processes for preparing same
CA2301336A1 (en) *	2000-03-17	2001-09-17	Michael T. Kelly	Topical treatment of rosacea
KR20080036661A (ko)	2000-12-18	2008-04-28	큐비스트 파마슈티컬즈 인코포레이티드	정제된 리포펩티드의 제조 방법
US20060014674A1 (en)	2000-12-18	2006-01-19	Dennis Keith	Methods for preparing purified lipopeptides
EP1423414A4 (de)	2001-08-06	2005-11-30	Cubist Pharm Inc	Neue depsipeptide und verfahren zu deren herstellung
EP1932853A1 (de)	2001-08-06	2008-06-18	Cubist Pharmaceutical Inc.	Neue Depsipeptide und Herstellungsverfahren dafür
US7049329B2 (en) *	2002-05-16	2006-05-23	Sepracor Inc.	Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
WO2003103699A1 (en)	2002-06-06	2003-12-18	Vicuron Pharmaceuticals Inc.	Use of ramoplanin to treat diseases associated with the use of antibiotics
CA2495144A1 (en) *	2002-08-29	2004-03-11	Activbiotics, Inc.	Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
US7145762B2 (en) *	2003-02-11	2006-12-05	Taser International, Inc.	Systems and methods for immobilizing using plural energy stores
KR100554481B1 (ko) *	2004-06-30	2006-03-03	씨제이 주식회사	반코마이신 염산염의 정제방법
US20080171766A1 (en) *	2005-03-10	2008-07-17	Smithkline Beecham Corporation	Novel Method
EP2018864A1 (de)	2007-07-23	2009-01-28	Biomet Deutschland GmbH	Pharmazeutische Zusammensetzung, Substrat mit einer pharmazeutischen Zusammensetzung und Verwendung einer pharmazeutischen Zusammensetzung
AU2008326297B2 (en)	2007-11-21	2012-11-08	Cipla USA, Inc.	Antibacterial aminoglycoside analogs
US20110076778A1 (en) *	2008-05-21	2011-03-31	Daedalus Innovations Llc	Solubilization of proteins in reverse micelles by extraction from a solid support
WO2009144739A1 (en) *	2008-05-26	2009-12-03	Biocon Limited	Amorphous daptomycin and a method of purification thereof
DE102008046610A1 (de) *	2008-09-09	2010-03-11	Biomet Deutschland Gmbh	Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt
RU2526391C2 (ru) *	2009-02-19	2014-08-20	Кселлия Фармасьютикалз Апс	Способ очистки липопептидов
CN101830970B (zh) *	2009-03-12	2012-06-27	成都雅途生物技术有限公司	一种高纯度达托霉素(Daptomycin)的纯化制备方法
CN101899094B (zh) *	2009-06-01	2012-11-21	安徽丰原发酵技术工程研究有限公司	一种高纯达托霉素的制备方法
WO2011002258A2 (ko) *	2009-07-02	2011-01-06	한양대학교 산학협력단	아르기닌 기제 양친성 펩티드 마이셀
WO2011035108A1 (en) *	2009-09-17	2011-03-24	Eagle Pharmaceuticals, Inc.	Formulations of daptomycin
EP2504020A4 (de) *	2009-11-23	2013-05-29	Eagle Pharmaceuticals Inc	Daptomycin-formulierungen
HUE039967T2 (hu) *	2009-11-23	2019-02-28	Cubist Pharmaceuticals Llc	Lipopeptid kompozíció és ezzel kapcsolatos eljárások
CN101777094B (zh) *	2010-02-01	2011-11-16	天津大学	达托霉素生产菌玫瑰孢链霉菌的代谢网络分析方法
KR101151878B1 (ko) *	2010-06-08	2012-05-31	미원상사주식회사	지방산 트리펩타이드염 및 이를 함유하는 항균 조성물
CN102276696B (zh) *	2010-06-09	2014-11-05	上海来益生物药物研究开发中心有限责任公司	达托霉素的纯化方法
RU2448725C2 (ru) *	2010-07-13	2012-04-27	Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации	Способ повышения бактерицидной активности
CN101957348B (zh) *	2010-09-17	2012-07-25	中华人民共和国珠海出入境检验检疫局	同时检测食品中氟喹诺酮类药物和氯霉素类药物的方法
KR200457763Y1 (ko) *	2010-09-30	2012-01-02	상 택 임	형광등 낙하 방지 기능을 갖는 안전소켓
JP5913367B2 (ja)	2011-01-05	2016-04-27	ホスピーラインコーポレイテッド	バンコマイシンの噴霧乾燥
CN102206694B (zh) *	2011-04-06	2013-10-16	山东新时代药业有限公司	一种含有癸酸的缓释组合物
WO2013012101A1 (ko) *	2011-07-15	2013-01-24	미원상사주식회사	지방산 트리펩타이드염 및 이를 함유하는 항균 조성물
CN103159829B (zh) *	2011-12-08	2014-11-05	北大方正集团有限公司	达托霉素的提取方法
CN102492024A (zh) *	2011-12-09	2012-06-13	厦门大学	从发酵液中提取达托霉素的方法
CN102675426B (zh) *	2012-04-26	2013-12-11	杭州华东医药集团生物工程研究所有限公司	一种达托霉素的提取纯化方法
WO2013173676A1 (en) *	2012-05-18	2013-11-21	Tufts Medical Center, Inc	Polypeptide and lipophilic moiety conjugate compositions, formulations, and uses related thereto
US8809314B1 (en)	2012-09-07	2014-08-19	Cubist Pharmacueticals, Inc.	Cephalosporin compound
WO2014041425A1 (en)	2012-09-11	2014-03-20	Hospira Australia Pty Ltd.	Daptomycin formulations and uses thereof
CN103724400B (zh) *	2012-10-10	2015-12-16	北大方正集团有限公司	一种分离纯化脱水达托霉素的方法
CN103848894A (zh) *	2012-11-30	2014-06-11	杨子剑	含有达托霉素结构的新化合物以及制备方法和用途
CN104043104B (zh)	2013-03-15	2018-07-10	浙江创新生物有限公司	含盐酸万古霉素的喷雾干粉及其工业化制备方法
CN103224547B (zh) *	2013-04-28	2015-05-20	华北制药集团新药研究开发有限责任公司	一种达托霉素的分离纯化方法
CN104511011A (zh) *	2013-09-29	2015-04-15	山东新时代药业有限公司	一种达托霉素无菌粉末及其制备方法
CN104650189A (zh) *	2013-11-19	2015-05-27	北大方正集团有限公司	一种异构达托霉素的制备方法
KR101601089B1 (ko) *	2014-04-22	2016-03-09	주식회사 종근당바이오	신규한 답토마이신 생산 균주 및 이를 이용한 답토마이신의 제조방법
BR112017000898A2 (pt)	2014-07-17	2017-11-21	The Medicines Co	oritavancina de alta pureza e método de produção da mesma
CN104387444B (zh) *	2014-11-13	2017-12-08	北大医药重庆大新药业股份有限公司	一种达托霉素杂质rs‑2高纯度样品的制备方法
KR101716879B1 (ko) *	2014-11-19	2017-03-17	주식회사 종근당바이오	데카노일 글리세라이드를 이용한 답토마이신의 생산방법
AR100034A1 (es) *	2015-01-30	2016-09-07	Consejo Nac De Investig Científicas Y Técnicas (Conicet)	Una composición farmacéutica soluble en agua que comprende, al menos, una sustancia terapéuticamente activa y, al menos, una sustancia con capacidad para formar micelas
CN105001305A (zh) *	2015-04-29	2015-10-28	利穗科技(苏州)有限公司	利用层析技术提取高纯度达托霉素的方法
CN106866791A (zh) *	2015-12-11	2017-06-20	北大方正集团有限公司	一种高纯度达托霉素内酯水解物的制备方法
CN106866790A (zh) *	2015-12-11	2017-06-20	北大方正集团有限公司	达托霉素RS-5/6、RS-7和RS-7a/7b杂质的制备方法
CN106866789A (zh) *	2015-12-11	2017-06-20	北大方正集团有限公司	一种分离纯化达托霉素rs-8杂质的方法
US10647746B2 (en)	2016-04-08	2020-05-12	Versitech Limited	Antibacterial cyclic lipopeptides
US11667674B2 (en)	2016-04-08	2023-06-06	Versitech Limited	Antibacterial cyclic lipopeptides
IT201600127655A1 (it)	2016-12-16	2018-06-16	Gnosis Spa	Processo per la purificazione di antibiotici lipopolipeptidici
CN115990296A (zh)	2017-09-22	2023-04-21	贝克顿·迪金森公司	用作导管封管液的4%柠檬酸三钠溶液
CN109589306A (zh) *	2017-09-30	2019-04-09	上海交通大学医学院附属第九人民医院	脂质体在制备用于清除蛋白结合毒素的药物制剂中的用途
CN107817307B (zh) *	2017-11-01	2020-12-25	重庆华邦制药有限公司	Hplc法分离测定帕司烟肼及其相关杂质的方法
CN109828037B (zh) *	2017-11-23	2021-11-23	中国科学院大连化学物理研究所	一种高通量富集和鉴定内源性n/o-连接糖肽的方法
US11964040B2 (en)	2017-12-28	2024-04-23	Locus Solutions Ipco, Llc	Oral health composition comprising purified biosurfactants and/or their derivatives
PL237299B1 (pl) *	2018-02-09	2021-04-06	Boruta Zachem Biochemia Spolka Z Ograniczona Odpowiedzialnoscia	Sposób oczyszczania i/lub rozdzielania surfaktyny z wykorzystaniem Chromatografii Przeciwprądowej
CN108333272A (zh) *	2018-03-02	2018-07-27	重庆华邦胜凯制药有限公司	Lc-msms法分离测定对氨基水杨酸及其相关杂质的方法
CN110339342A (zh) *	2018-04-03	2019-10-18	江苏恒瑞医药股份有限公司	一种达托霉素的盐或含盐的组合物及其制备方法
CN110577581A (zh) *	2018-06-07	2019-12-17	美国蓝博药业公司	一种新型的抑菌脂肽化合物、制备方法及其应用
WO2020018888A1 (en)	2018-07-20	2020-01-23	The Board Of Regents Of The University Of Oklahoma	Antimicrobial peptides and methods of use
WO2020128506A1 (en) *	2018-12-21	2020-06-25	Arecor Limited	Novel composition
CN111366644B (zh) *	2018-12-25	2022-07-26	江苏先声药业有限公司	一种比阿培南侧链有关物质的hplc检测方法
CN109444294B (zh) *	2018-12-27	2021-06-22	苏州莱奥生物技术有限公司	一种分离利奈唑胺和其手性异构体的高效液相色谱方法
CN109917047A (zh) *	2019-04-15	2019-06-21	陕西科技大学	超高效液相色谱-四极杆飞行时间质谱法同时筛查鱼中多类别药物残留的方法
CN110146620B (zh) *	2019-06-11	2022-04-19	福建医科大学孟超肝胆医院(福州市传染病医院)	一种uplc-ms/ms法同时检测血浆中五种抗结核药物的方法
CN113004373B (zh) *	2019-12-19	2024-08-13	鲁南制药集团股份有限公司	一种达托霉素的纯化方法
JP2023517926A (ja)	2020-03-12	2023-04-27	バクスター・インターナショナル・インコーポレイテッド	ソルビトールとマンニトールの組み合わせを含むダプトマイシン製剤
CN113929747A (zh) *	2020-06-29	2022-01-14	鲁南制药集团股份有限公司	一种制备达托霉素杂质RS-7a的方法
CN113929743A (zh) *	2020-06-29	2022-01-14	鲁南制药集团股份有限公司	一种制备达托霉素杂质rs-1和杂质rs-3的方法
CN111892647B (zh) *	2020-08-18	2022-04-29	丽珠集团福州福兴医药有限公司	一种提高达托霉素发酵产量的补料方法
CN112089823B (zh) *	2020-09-25	2024-02-06	珠海中科先进技术研究院有限公司	一种短梗霉素a和制霉菌素组合物及其复合软膏、凝胶剂以及喷剂
CN112684043A (zh) *	2020-12-16	2021-04-20	南京健友生化制药股份有限公司	一种达托霉素有关物质的检测方法
EP4248951A4 (de) *	2020-12-22	2024-10-23	Chugai Pharmaceutical Co Ltd	Verfahren zur herstellung von arzneimitteln mit gefriertrocknungsschritt mit gemischtem lösungsmittel
CN112898383A (zh) *	2021-01-29	2021-06-04	深圳海创生物科技有限公司	一种寡肽、活性肽组合物及其在制备具有抗炎作用的产品中的应用
CN113866330B (zh) *	2021-10-26	2023-08-22	丽珠集团福州福兴医药有限公司	一种脱水达托霉素的分离纯化方法和应用

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US21978A (en)		1858-11-02		Trap for animals
USRE21978E (en)		1941-12-16		Vacuum cleaner
US3854480A (en)	1969-04-01	1974-12-17	Alza Corp	Drug-delivery system
USRE32333E (en)	1978-10-16	1987-01-20	Eli Lilly And Company	A-21978 Antibiotics and process for their production
USRE32455E (en)	1978-10-16	1987-07-07	Eli Lilly And Company	A-21978 antibiotics and process for their production
US4331594A (en) *	1978-10-16	1982-05-25	Eli Lilly And Company	A-21978 Antibiotics and process for their production
EP0014815A3 (de)	1978-12-20	1980-10-29	Ciba-Geigy Ag	Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
AU563067B2 (en)	1982-02-27	1987-06-25	Beecham Group Plc	Heterocyclic normonyl derivatives
USRE32310E (en)	1982-05-21	1986-12-16	Eli Lilly And Company	Derivatives of A-21978C cyclic peptides
US4524135A (en)	1982-05-21	1985-06-18	Eli Lilly And Company	A-21978C cyclic peptides
USRE32311E (en)	1982-05-21	1986-12-16	Eli Lilly And Company	Derivatives of A-21978C cyclic peptides
IL68700A0 (en)	1982-05-21	1983-09-30	Lilly Co Eli	Improvements relating to a-21978c cyclic peptide derivatives and their production
US4482487A (en)	1982-05-21	1984-11-13	Eli Lilly And Company	A-21978C cyclic peptides
US4537717A (en)	1982-05-21	1985-08-27	Eli Lilly And Company	Derivatives of A-21978C cyclic peptides
US4452775A (en)	1982-12-03	1984-06-05	Syntex (U.S.A.) Inc.	Cholesterol matrix delivery system for sustained release of macromolecules
US4885243A (en)	1984-10-09	1989-12-05	Eli Lilly And Company	Process for producing A-21978C derivatives
HU196845B (en)	1984-10-09	1989-01-30	Lilly Co Eli	Process for producing a-21978 c derivatives
US4800157A (en)	1985-09-09	1989-01-24	Eli Lilly And Company	Process for producing the A-21978C antibiotics
US4865729A (en)	1985-11-04	1989-09-12	Sepragen Corporation	Radial thin layer chromatography
US4840730A (en)	1986-07-25	1989-06-20	Sepragen Corporation	Chromatography system using horizontal flow columns
US4708782A (en)	1986-09-15	1987-11-24	Sepragen Corporation	Chromatography column-electrophoresis system
CA1319886C (en)	1987-02-03	1993-07-06	Alberto Ferro	Mixed micelle solutions
ZA883887B (en)	1987-06-10	1990-02-28	Lilly Co Eli	Chromatographic purification process
EP0294990A3 (de)	1987-06-10	1990-05-09	Eli Lilly And Company	Chromatographisches Reinigungsverfahren
US4874843A (en)	1987-12-03	1989-10-17	Eli Lilly And Company	Chromatographic purification process
US5271935A (en)	1988-02-05	1993-12-21	Hoechst Aktiengesellschaft	Antibiotic, cammunocin, a process for the preparation thereof, and the use thereof as a pharmaceutical
CA1337758C (en)	1988-04-11	1995-12-19	Eli Lilly And Company	Peptide antibiotics
ZA901622B (en) *	1989-03-06	1991-11-27	Lilly Co Eli	An improved diluent formulation for daptomycin
US5202309A (en)	1989-06-30	1993-04-13	Merck & Co., Inc.	Antibiotic cyclopeptide fermentation product
DK0438813T3 (da)	1990-01-26	1998-07-27	Hoechst Ag	Nyt antibiotikum, deoxymulundocandin, en fremgangsmåde til dets fremstilling samt dets anvendelse som lægemiddel
DK0460882T3 (da)	1990-06-07	1996-08-26	Lilly Co Eli	Lipopeptiddeacylase
JPH04167172A (ja)	1990-10-31	1992-06-15	Nec Corp	ベクトルプロセッサ
JPH04224197A (ja)	1990-12-26	1992-08-13	Fujitsu Ltd	生体高分子結晶化方法および装置
US5336756A (en)	1991-05-01	1994-08-09	Merck & Co., Inc.	Process for crystalline cyclic lipopeptides
TW213468B (de)	1991-06-29	1993-09-21	Hoechst Ag
WO1993021207A1 (en)	1992-04-20	1993-10-28	Abbott Laboratories	Process for making vancomycin
TW455591B (en) *	1993-06-08	2001-09-21	Hoechst Ag	Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
WO1995005384A1 (en)	1993-08-13	1995-02-23	Smithkline Beecham Plc	Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
US5756680A (en)	1994-01-05	1998-05-26	Sepragen Corporation	Sequential separation of whey proteins and formulations thereof
DE4411025A1 (de)	1994-03-30	1995-10-05	Hoechst Ag	Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
IT1275427B (it) *	1995-05-16	1997-08-07	Bracco Spa	Processo per la depirogenazione di soluzioni farmaceutiche iniettabili
US5955509A (en)	1996-05-01	1999-09-21	Board Of Regents, The University Of Texas System	pH dependent polymer micelles
FR2755857B1 (fr)	1996-11-19	1998-12-24	Rhone Poulenc Rorer Sa	Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
WO1999027957A1 (en)	1997-12-03	1999-06-10	The Immune Response Corporation	Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides
FR2771640B1 (fr)	1997-12-03	2000-02-11	Inst Nat Sante Rech Med	Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques
FR2772272B1 (fr)	1997-12-16	2000-01-14	Rhone Poulenc Rorer Sa	Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
FR2774687B1 (fr) *	1998-02-06	2002-03-22	Inst Nat Sante Rech Med	Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques
DE19807972A1 (de)	1998-02-25	1999-08-26	Hoechst Marion Roussel De Gmbh	Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
EP2311436A1 (de)	1998-04-27	2011-04-20	Altus Pharmaceuticals Inc.	Stabilisierte Protein-Kristalle, diese enthaltende Formulierungen und ihre Herstellungsverfahren
AU5331199A (en)	1998-08-07	2000-02-28	Merck & Co., Inc.	Method for the production of an antibiotic agent
DE122006000049I1 (de)	1998-09-25	2007-01-04	Cubist Pharm Inc	Verwendung von Daptomycin
CN1425025A (zh)	1999-12-15	2003-06-18	卡比斯特制药公司	作为抗菌剂的新颖的脂肽
EP1246838A1 (de)	1999-12-15	2002-10-09	Cubist Pharmaceuticals, Inc.	Lipopeptide als antibacterielle verbindungen
IL150224A0 (en)	1999-12-15	2002-12-01	Cubist Pharm Inc	Lipopeptides and pharmaceutical compositions containing the same
US6696412B1 (en)	2000-01-20	2004-02-24	Cubist Pharmaceuticals, Inc.	High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en)	2000-12-18	2006-01-19	Dennis Keith	Methods for preparing purified lipopeptides
KR20080036661A (ko)	2000-12-18	2008-04-28	큐비스트 파마슈티컬즈 인코포레이티드	정제된 리포펩티드의 제조 방법
WO2002059145A1 (en)	2000-12-18	2002-08-01	Cubist Pharmaceuticals, Inc.	Methods for preparing purified lipopeptides
KR20040032891A (ko)	2001-08-06	2004-04-17	큐비스트 파마슈티컬즈 인코포레이티드	답토마이신 생합성 유전자 클러스터에 관련된 조성물 및방법
US20030144362A1 (en)	2002-01-28	2003-07-31	Utterberg David S.	High viscosity antibacterials for cannulae
US8912174B2 (en)	2003-04-16	2014-12-16	Mylan Pharmaceuticals Inc.	Formulations and methods for treating rhinosinusitis
WO2004104019A2 (en)	2003-05-14	2004-12-02	Zengen, Inc.	Anti-inflammatory/anti-microbial peptides for use in dialysis
US8003673B2 (en)	2005-05-31	2011-08-23	Cubist Pharmaceuticals, Inc.	Daptomycin for the treatment of biofilm and catheter salvage
US9393093B2 (en)	2008-02-18	2016-07-19	Covidien Lp	Clip for implant deployment device
WO2011035108A1 (en)	2009-09-17	2011-03-24	Eagle Pharmaceuticals, Inc.	Formulations of daptomycin
HUE039967T2 (hu)	2009-11-23	2019-02-28	Cubist Pharmaceuticals Llc	Lipopeptid kompozíció és ezzel kapcsolatos eljárások
US9406568B2 (en)	2014-11-21	2016-08-02	International Business Machines Corporation	Semiconductor structure containing low-resistance source and drain contacts

2000
- 2000-11-28 US US09/735,191 patent/US6696412B1/en not_active Expired - Lifetime
2001
- 2001-01-18 CN CN201710025711.8A patent/CN107082798B/zh not_active Expired - Lifetime
- 2001-01-18 BR BRPI0107731A patent/BRPI0107731B8/pt not_active IP Right Cessation
- 2001-01-18 DE DE60140631T patent/DE60140631D1/de not_active Expired - Lifetime
- 2001-01-18 KR KR1020027009279A patent/KR101174140B1/ko active IP Right Grant
- 2001-01-18 PL PL400575A patent/PL226956B1/pl unknown
- 2001-01-18 AT AT05015374T patent/ATE449785T1/de active
- 2001-01-18 AU AU30978/01A patent/AU784937B2/en not_active Expired
- 2001-01-18 PT PT05015374T patent/PT1586580E/pt unknown
- 2001-01-18 CN CN01805212A patent/CN1404487A/zh active Pending
- 2001-01-18 DE DE60115383T patent/DE60115383T2/de not_active Expired - Lifetime
- 2001-01-18 HU HU0203969A patent/HUP0203969A2/hu unknown
- 2001-01-18 AT AT01903121T patent/ATE311405T1/de active
- 2001-01-18 ES ES15173312T patent/ES2799702T3/es not_active Expired - Lifetime
- 2001-01-18 EP EP09014616A patent/EP2159229A1/de not_active Withdrawn
- 2001-01-18 KR KR1020077008648A patent/KR20070044079A/ko not_active Application Discontinuation
- 2001-01-18 WO PCT/US2001/001748 patent/WO2001053330A2/en active Application Filing
- 2001-01-18 PT PT101748622T patent/PT2264047E/pt unknown
- 2001-01-18 KR KR1020117023193A patent/KR20110126737A/ko not_active Application Discontinuation
- 2001-01-18 PL PL416764A patent/PL236352B1/pl unknown
- 2001-01-18 CZ CZ2012-332A patent/CZ307877B6/cs not_active IP Right Cessation
- 2001-01-18 ES ES05015374T patent/ES2336336T3/es not_active Expired - Lifetime
- 2001-01-18 CA CA2743326A patent/CA2743326C/en not_active Expired - Lifetime
- 2001-01-18 NZ NZ520324A patent/NZ520324A/en not_active IP Right Cessation
- 2001-01-18 ES ES15173324T patent/ES2799706T3/es not_active Expired - Lifetime
- 2001-01-18 CA CA2398726A patent/CA2398726C/en not_active Expired - Lifetime
- 2001-01-18 MX MXPA02007132A patent/MXPA02007132A/es active IP Right Grant
- 2001-01-18 CZ CZ2002-2830A patent/CZ305004B6/cs not_active IP Right Cessation
- 2001-01-18 IL IL15073301A patent/IL150733A0/xx unknown
- 2001-01-18 EP EP05015374A patent/EP1586580B1/de not_active Expired - Lifetime
- 2001-01-18 PL PL356898A patent/PL214000B1/pl unknown
- 2001-01-18 DK DK05015374.1T patent/DK1586580T3/da active
- 2001-01-18 EP EP15173324.3A patent/EP2940036B1/de not_active Expired - Lifetime
- 2001-01-18 CN CN200810087401XA patent/CN101240013B/zh not_active Expired - Lifetime
- 2001-01-18 RU RU2002122114/13A patent/RU2311460C9/ru active
- 2001-01-18 ES ES10174862.2T patent/ES2547281T3/es not_active Expired - Lifetime
- 2001-01-18 EP EP10174862.2A patent/EP2264047B1/de not_active Expired - Lifetime
- 2001-01-18 EP EP15173312.8A patent/EP2940034B1/de not_active Expired - Lifetime
- 2001-01-18 CN CN2012100807774A patent/CN102671181A/zh active Pending
- 2001-01-18 EP EP01903121A patent/EP1252179B1/de not_active Expired - Lifetime
- 2001-01-18 JP JP2001553802A patent/JP5303087B2/ja not_active Expired - Lifetime
- 2001-01-18 KR KR1020127011479A patent/KR101291494B1/ko active IP Right Grant
- 2001-01-18 CN CN201110133359.2A patent/CN102229650B/zh not_active Expired - Lifetime
- 2001-01-18 DK DK10174862.2T patent/DK2264047T3/en active
2002
- 2002-07-12 IS IS6470A patent/IS6470A/is unknown
- 2002-07-19 NO NO20023476A patent/NO20023476L/no not_active Application Discontinuation
2003
- 2003-09-11 HK HK03106508.9A patent/HK1054240A1/zh unknown
- 2003-12-29 US US10/747,485 patent/US20050009747A1/en not_active Abandoned
2006
- 2006-04-19 HK HK06104688.3A patent/HK1085746A1/xx not_active IP Right Cessation
2007
- 2007-04-24 US US11/739,180 patent/US8058238B2/en not_active Expired - Fee Related
2009
- 2009-02-12 HK HK09101340.6A patent/HK1120528A1/xx not_active IP Right Cessation
2010
- 2010-02-19 CY CY20101100167T patent/CY1109846T1/el unknown
- 2010-09-22 US US12/888,233 patent/US8129342B2/en not_active Expired - Fee Related
2011
- 2011-06-07 HK HK11105628.6A patent/HK1151546A1/xx not_active IP Right Cessation
2012
- 2012-02-16 US US13/398,219 patent/US8604164B2/en not_active Expired - Fee Related
- 2012-05-20 IL IL219889A patent/IL219889A/en active IP Right Grant
2013
- 2013-05-07 JP JP2013097659A patent/JP5631439B2/ja not_active Expired - Lifetime
- 2013-05-29 IL IL226636A patent/IL226636A/en active IP Right Grant
- 2013-06-14 US US13/918,083 patent/US8853357B2/en not_active Expired - Fee Related
2014
- 2014-09-02 US US14/475,319 patent/US9358267B2/en not_active Expired - Fee Related
2015
- 2015-09-22 CY CY20151100831T patent/CY1116827T1/el unknown
2016
- 2016-04-29 HK HK16104932.5A patent/HK1217205A1/zh unknown
- 2016-04-29 HK HK16104925.4A patent/HK1217204A1/zh unknown

Also Published As

Publication number	Publication date
CN107082798B (zh)	2021-10-15
BR0107731A (pt)	2002-10-01
JP5631439B2 (ja)	2014-11-26
AU3097801A (en)	2001-07-31
CN102671181A (zh)	2012-09-19
CN101240013B (zh)	2012-05-23
CN102229650B (zh)	2014-03-12
IL219889A (en)	2017-01-31
CA2743326A1 (en)	2001-07-26
DE60115383D1 (de)	2006-01-05
AU784937B2 (en)	2006-08-03
HK1120528A1 (en)	2009-04-03
ES2799706T3 (es)	2020-12-21
KR20120065440A (ko)	2012-06-20
CZ20022830A3 (cs)	2002-11-13
HK1085746A1 (en)	2006-09-01
US20130280760A1 (en)	2013-10-24
ES2799702T3 (es)	2020-12-21
DE60115383T2 (de)	2006-08-17
CN1404487A (zh)	2003-03-19
KR20020083151A (ko)	2002-11-01
KR20110126737A (ko)	2011-11-23
ATE311405T1 (de)	2005-12-15
RU2311460C9 (ru)	2009-06-10
MXPA02007132A (es)	2004-10-14
NO20023476D0 (no)	2002-07-19
EP1586580A3 (de)	2005-11-09
CN101240013A (zh)	2008-08-13
CA2743326C (en)	2015-04-07
DK2264047T3 (en)	2015-07-13
PL416764A1 (pl)	2016-05-23
IL226636A0 (en)	2013-06-27
HK1151546A1 (en)	2012-02-03
ES2547281T3 (es)	2015-10-02
DK1586580T3 (da)	2010-03-29
US8129342B2 (en)	2012-03-06
WO2001053330A3 (en)	2002-04-18
EP1586580A2 (de)	2005-10-19
ATE449785T1 (de)	2009-12-15
US8058238B2 (en)	2011-11-15
JP5303087B2 (ja)	2013-10-02
NZ520324A (en)	2004-06-25
US9358267B2 (en)	2016-06-07
EP1252179B1 (de)	2005-11-30
US6696412B1 (en)	2004-02-24
HK1054240A1 (zh)	2003-11-21
IL219889A0 (en)	2012-06-28
PL226956B1 (pl)	2017-10-31
RU2002122114A (ru)	2004-02-27
EP2940034A1 (de)	2015-11-04
HUP0203969A2 (hu)	2003-03-28
US20050009747A1 (en)	2005-01-13
JP2013173785A (ja)	2013-09-05
CZ307877B6 (cs)	2019-07-17
ES2336336T3 (es)	2010-04-12
PL356898A1 (en)	2004-07-12
PL236352B1 (pl)	2021-01-11
US20070191280A1 (en)	2007-08-16
EP1252179A2 (de)	2002-10-30
EP2940036B1 (de)	2020-05-06
CY1116827T1 (el)	2018-03-07
CZ305004B6 (cs)	2015-03-25
US20110207658A1 (en)	2011-08-25
EP2940034B1 (de)	2020-05-06
IS6470A (is)	2002-07-12
PL400575A1 (pl)	2013-01-07
US20120149062A1 (en)	2012-06-14
BRPI0107731B1 (pt)	2015-08-11
EP2940036A1 (de)	2015-11-04
CA2398726A1 (en)	2001-07-26
IL226636A (en)	2017-03-30
EP1586580B1 (de)	2009-11-25
CN107082798A (zh)	2017-08-22
CY1109846T1 (el)	2014-09-10
KR101291494B1 (ko)	2013-10-17
US20140371135A1 (en)	2014-12-18
HK1217204A1 (zh)	2016-12-30
PL214000B1 (pl)	2013-06-28
BRPI0107731B8 (pt)	2021-05-25
JP2003520807A (ja)	2003-07-08
CN102229650A (zh)	2011-11-02
WO2001053330A9 (en)	2002-10-17
EP2159229A1 (de)	2010-03-03
KR20070044079A (ko)	2007-04-26
EP2264047B1 (de)	2015-06-24
DE60140631D1 (de)	2010-01-07
US8604164B2 (en)	2013-12-10
PT1586580E (pt)	2010-02-17
PT2264047E (pt)	2015-09-22
WO2001053330A2 (en)	2001-07-26
RU2311460C2 (ru)	2007-11-27
CA2398726C (en)	2012-01-10
HK1217205A1 (zh)	2016-12-30
IL150733A0 (en)	2003-02-12
KR101174140B1 (ko)	2012-08-14
US8853357B2 (en)	2014-10-07
EP2264047A1 (de)	2010-12-22

Publication	Publication Date	Title
NO20023476L (no)	2002-09-20	Höyrenhets lipopeptider, lipopeptid miceller og fremgangsmåte for fremstilling av disse og farmasöytiske sammensetninger sominneholder dem
WO2001044272A3 (en)	2001-11-29	Daptomycin analogs as antibacterial agents
WO2001044271A3 (en)	2002-03-07	Daptomycin analogs and their use as antibacterial agents
ATE535539T1 (de)	2011-12-15	Verfahren zur herstellung gereinigter lipopeptide
HUP0302519A2 (hu)	2003-12-29	Az atorvasztatin kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MXPA02006030A (es)	2004-08-23	Lipopeptidos como agentes antibacterianos.
AU2002353775A1 (en)	2003-03-10	Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
DK0854874T3 (da)	2003-06-02	Makrocykliske lactonforbindelser og fremgangsmåde til fremstilling af disse
TW200505939A (en)	2005-02-16	Process for production of cyclic peptides
WO2002085921A3 (de)	2003-04-24	Einfaches verfahren zur synthese von boswelliasäuren und derivaten davon
MY154979A (en)	2015-08-28	Novel plasminogen activator fusion proteins as thrombolytic agents
CA2415097A1 (en)	2002-02-07	Process and intermediate compounds for the preparation of pyrrolidines
WO2001032845A3 (en)	2001-11-22	Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith
MX9801665A (es)	1998-08-30	Polimorfos del profarmaco de 6-n-(l-ala-l-ala)-trovafloxacina, procedimiento para su preparacion y uso de los mismos.

Legal Events

Date	Code	Title	Description
2005-09-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application